Yanagisawa K - Search Results

1

Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.

Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP. Amann J, et al. Among authors: yanagisawa k. Cancer Res. 2005 Jan 1;65(1):226-35. Cancer Res. 2005. PMID: 15665299

2

Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.

Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T, Takahashi T. Yanagisawa K, et al. Cancer Res. 1996 Dec 15;56(24):5579-82. Cancer Res. 1996. PMID: 8971157

3

Molecular cloning of human TAK1 and its mutational analysis in human lung cancer.

Kondo M, Osada H, Uchida K, Yanagisawa K, Masuda A, Takagi K, Takahashi T, Takahashi T. Kondo M, et al. Among authors: yanagisawa k. Int J Cancer. 1998 Feb 9;75(4):559-63. doi: 10.1002/(sici)1097-0215(19980209)75:4<559::aid-ijc11>3.0.co;2-4. Int J Cancer. 1998. PMID: 9466656 Free article.

4

Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.

Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T. Osada H, et al. Among authors: yanagisawa k. Cancer Res. 2001 Nov 15;61(22):8331-9. Cancer Res. 2001. PMID: 11719467

5

Proteomic patterns of tumour subsets in non-small-cell lung cancer.

Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP. Yanagisawa K, et al. Lancet. 2003 Aug 9;362(9382):433-9. doi: 10.1016/S0140-6736(03)14068-8. Lancet. 2003. PMID: 12927430

6

A training-testing approach to the molecular classification of resected non-small cell lung cancer.

Yamagata N, Shyr Y, Yanagisawa K, Edgerton M, Dang TP, Gonzalez A, Nadaf S, Larsen P, Roberts JR, Nesbitt JC, Jensen R, Levy S, Moore JH, Minna JD, Carbone DP. Yamagata N, et al. Among authors: yanagisawa k. Clin Cancer Res. 2003 Oct 15;9(13):4695-704. Clin Cancer Res. 2003. PMID: 14581339

7

Molecular fingerprinting in human lung cancer.

Yanagisawa K, Xu BJ, Carbone DP, Caprioli RM. Yanagisawa K, et al. Clin Lung Cancer. 2003 Sep;5(2):113-8. doi: 10.3816/CLC.2003.n.025. Clin Lung Cancer. 2003. PMID: 14596694 Review.

8

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. Takamizawa J, et al. Among authors: yanagisawa k. Cancer Res. 2004 Jun 1;64(11):3753-6. doi: 10.1158/0008-5472.CAN-04-0637. Cancer Res. 2004. PMID: 15172979

9

Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines.

Nakagawa T, Hayashita Y, Maeno K, Masuda A, Sugito N, Osada H, Yanagisawa K, Ebi H, Shimokata K, Takahashi T. Nakagawa T, et al. Among authors: yanagisawa k. Cancer Res. 2004 Jul 15;64(14):4826-32. doi: 10.1158/0008-5472.CAN-04-0871. Cancer Res. 2004. PMID: 15256452

10

Combination therapy with conditionally replicating adenovirus and replication defective adenovirus.

Lee CT, Park KH, Yanagisawa K, Adachi Y, Ohm JE, Nadaf S, Dikov MM, Curiel DT, Carbone DP. Lee CT, et al. Among authors: yanagisawa k. Cancer Res. 2004 Sep 15;64(18):6660-5. doi: 10.1158/0008-5472.CAN-04-1200. Cancer Res. 2004. PMID: 15374981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

912 results

Search Page